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increased SI from 0.14 + 0.06 lo 0.16 * 0.05 (p=O.O2), while EF increased from 24 * 8 lo 
32 * 8 %, (p=O.O2). 
Conclusion: SI represents an efficient measure of lefl ventricular synchrony. 
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1187-2 Combining Electrical Therapies for Heart Failure: The 
Milan Experience With Biventricular Pacing- 
Defibrillation Backup Combination in Patients Without 
Standard Indication for Implantable Cardioverter 
Defibrillators 
Salvatore Rosanio, Gabnele Vicedomini, Giuseppe Augello. Patrlzlo Mazzone, Simone 
Gullelta, Cosimo Dicandia, Alessia Pappone, Gabriele Paglino, Mario Pitt&, Carlo 
Pappone, San Raffaele University Hospital, Milan, Italy 
Background: Biventrlcular pacing (BVP) improves hemodynamics and symptoms in 
heart failure (HF) pts with bundle branch block. Pts with left ventricular ejection fraction 
(EF) ~35% and life-threatening ventricular tachyarrhythmias are at high risk of sudden 
death (SD) and benefit most from implantable cardioverter-defibrillators (ICE&). To date, 
only limited information is available about the prophylactic use of ICDs in pts receiving 
BVP regardless of standard ICD indications. 
Objective: This study investigated the incidence of appropriate ICD interventions in pts 
indicated for BVP and their predictors. 
Methods: From January 1999 and April 2001, 143 consecutive pts indicated for BVP 
(aged, 57 f 12 yrs; 72% male; NYHA class, 2.5 * 1.6; EF 21 r 6%; ischemic etiology. 
43%; QRS duration. 162 * 24 ms) received adjunctive backup ICD. Pts were followed-up 
in our outpatient cardiac pacing clinic in 3- to *-month intervals or as soon as possible 
after spontaneous ICD shocks for device interrogation and retrieval of stored electro- 
grams, and included ECG and echocardiographic kxaminations. 
Results: Follow-up averaged 523 days, 31% of pts showed VTNF inducibility on electro- 
physiologic (EP) test and during follow-up, 13 (29%) of these 44 pts received successful 
appropriate interventions for ventricular tachycardia (VT) /ventricular fibrillation (VF) epi- 
sodes, compared with 32 (32%) of 99 pts with negative EP test. 78% of the VT episodes 
were converted to Sinus rhythm with antitachycardia pacing. Multivariate Cox analysis of 
baseline clinical variables and EP test results failed to identify VTNF inducibility as prs- 
dictor of appropriate ICD interventions during follow-up. There was no evidence that the 
predictive value of EP testing differed between ischemic and non-ischemic HF pts (ratio 
of hazard ratios, 0.66: P=O.76). 
Conclusion: Although with the limitations of an observational study, our data suggest 
that ICD backup grants increased security and emphasizes the Importance of prevent- 
able SDS III BVP pts without standard ICD indications. Further, these data suggest that 
the use of EP testing doesn’t help to identify BVP-indicated pts who benefit from ICD 
backup. 
1187-13 Ventricular Tachycardia Storm After Initiation of 
Biventricular Pacing in Patients With Prior Inferior- 
lnferolateral Myocardial Infarction 
Hemal M. Navak Joseph Poku, Erlca Zado, Andrea M. Russo, Francis E. Marchlinski, 
University of Pennsylvania, Philadelphia, PA 
Background: Biventricular pacing (BP) has been shown to reduce symptoms and 
improve functional class in pts with severs CHF, low EF and prolonged QRS duration. By 
reducing CHF, BP is thought to reduce the incidence of ventricular arrhythmias. How- 
ever, we have seen ventricular tachycardia storm (VTS) develop among some pts with 
CAD manifest by recurrent ICD shocks or therapy after initiation of BP. We sought to 
identify potential risk factors for the development of this VTS. Methods: We reviewed the 
records of 30 consecutive pts who underwent biventricular pacemaker-ICD implantation 
at our insdtutlon between Jan June 2002. Twenty had CAD and were used for analysis. 
VTS was defined as frequent and recurrent IX shocks and/or delivery of anti-tachycar- 
dia pacing due to SMVT in pts who previously had no clinical SMVT 3 months prior to the 
initiation of BP. Variables including age, sex. race, EF, location of infarction, indication for 
ICD therapy, anti-arrhythmic use percent pacing and coronary sinus lead position were 
identified as possible risk factors. Fisher’s exact test was used for analysis. 
Results: Four of the 20 pts (20%) developed VTS. of the variables listed, only the pres- 
ence of an inferior-inferolateral infarction was identified as a risk factor for the develop- 
ment of VTS. (p=.Ol) All 4 pts with VTS had an inferior-inferolateral infarction, implying 
that 40% of pts with an inferior-inferolateral infarction in this study group developed VTS. 
Conclusions: The presence of an inferior-inferolateral infarction was identified as a risk 
factor for developing VTS in pts with CAD in whom BP was Initiated. We hypothesize that 
pacing from the lateral left ventricle, as part of normal BP, may facilitate reentry and 
hence the induction of sustained monomorphic ventricular tachycardla in patients with 
inferior-inferolateral infarctions. 
1187-14 Plasma Markers of Clinical Improvement in Patients 
With End-Stage Heart Failure Treated With a 
Biventricular Pacemaker Device 
Ellen J. Jonaediik, Sander G. Molhoek, Jeroen J. Bax, Ernst E. van der Wall, Martin J. 
Schalij, Arnoud van der Laarse, Leiden University Medical Center, L&den, The 
Netherlands 
Background: The levels of the plasma hormones atrial and brain natriuretic peptide 
(ANP and BNP) are elevated and used as diagnostic and prognostic indicators for the 
treatment of patients with congestive heart failure. Tumor Necrosis Fador alfa (TNF-alfa) 
and endothelln-1 (ET-l) (marker for endothelial dysfunction) are correlated with the 
severity of heart fadure. Blventricular (BV) pacing results in clinical improvement I” 
patients with congestive heart failure and ventricular conduction disturbances. The objec- 
tive of this study was to evaluate the effect of BV pacing on plasma hormones 
(ANP,BNP), ET-l and TNF-alfa. 
Methods: 14 patients wtth end-stage heart failure (NYHA class Ill-IV), LBBB and QRS 
duration >120 ms received a BV pacing device and clinically improved (reduction in 
NYHA class 21) after 6 months of BV pacing therapy. At baseline and 6 months post- 
implantation the following parameters were evaluated: NYHA class, Minnesota Quality of 
Life (QOL) score and 6.minute walking distance. N-terminal pro-ANP hormone, N-termi- 
nal pro-BNP, ET-l and TNF-alfa plasma concentrations were evaluated before and after 
6 months of follow-up. 
Results: Table 
Conclusions: Six months of BV pacing therapy results in clinical improvement and a 
decrease of BNP-, ANP- and ET-l levels. TNF-alfa plasma concentrations were not 
affected by this therapy. Plasma ANP and BNP levels as well as ET-l levels 
can be used as markers of the clinical benefit in congestive heati failure patients, treated 
by BV pacing. 
NYHA class 
QOL score 
6-min Wl 
BNP (pmol/L) 
ANP (pmol/L) 
ET-l (pg/mL) 
TNF-alfa (pg/ML) 
Baseline 6 months follow-up 
3.1*0.3 1.9io.4 
36i16 24i13 
269i96 361*106 
1495i766 946+593 
11454+6612 8141+5072 
1.66kO.95 1.04*0.63 
39*27 36545 
P-value 
<O.Ol 
co.01 
<O.Ol 
co.01 
co.05 
co.05 
NS 
1187-15 Sustained Improvement in Peripheral Immune 
Responses by Biventricular Pacing and Its Association 
With Exercise Tolerance and Quality of Life 
Georae N. Theodorakls. Panagiota Flevari, Fotis Kolokathis, Efthimios G. Live& 
Stamatis Adamopoulos, Chrlstos Kroupis. Dionyssios Leftheriotls, Aikaterini Koniavitou. 
Dimitrios T. Kremastinos, Onassis Cardiac Surgery Center. Athens. Greece 
Background: To date, limited information exists regarding chronic inflammatory changes 
induced by biventricular pacing (BivP)and their relation with patients’(pts)fundlonal 
capacity and quality of life (QOL).Methods: Thirteen pts with heart failure (HF), NYHA 
class III-IV were studied (mean age 65*6 years, PR duration 192+17 msec, QRS dura- 
tion 195+22 msec, LV EF 23*5%). All were implanted a Biv defibrillator (n=ll) or pace- 
maker (n=2). After a preliminary no pacing period of 1 month (M) following device 
implantation (VVI 30 bpm), baseline evaluation was performed, including NYHA class 
assessment, treadmill exercise stress testing and QOL evaluation (Minnesota Question- 
naire). Serum levels of tumor necrosis factor-a (TNF-a). soluble TNF receptors (sTNFR-I, 
sTNFR-II) and interleukin-6 (IL-6) were assessed at that time point by ELISA. The same 
parameters were also evaluated I) after 3 M of BivP (VDD mode 30 bpm), ii) following a 
subsequent 3-M no pacing period.Results: An improvement was observed in clinical and 
inflammatory markers, sustained following therapy discontinuation (Table). Among the 
inflammatorv markers. the % reduction in IL-6 followina 3 M of oacina theraov was sianif- _ _ ._ - 
icantly related to the pacing-induced improvement in exercise duration (r=-0.055, p 
~0.05) and QOL status (r=0.73,p<0.05).Conclus1on. The improvement observed in func- 
tional capacity and QOL of HF pts by BivP pacing is associated with a reduction in IL-6 
and is sustained following 3 M of therapy discontinuation 
*: significant differences vs basehne 
NYHA 
Exercise duration (mln) 
QOL score 
TNF-a (pg/ml) 
sTNFR-I (pg/ml) 
sTNFR-II (pg/ml) 
IL-6 (pg/ml) 
Baseline 
2.6*0.4 
7.9*3.3 
43.6513.1 
2.1+1.3 
1626+561 
2796r766 
11.6+9.3 
BivP 
1.620.4 
9.5+2.5’ 
32.2+9.5 
1.6+0.7’ 
1402*360’ 
2467t650’ 
7.7k6.4 
No pacing 
1.9*0.3 
9.6*1.7’ 
29.6ztl2.1’ 
1.6+1.2* 
133Ot312’ 
2376iz-553 
5.5*3.9 
